Mayne Pharma | MYX - 税前利润



金融业
股票价格
AUD
资产
AUD 1.14B
现金及等价物
AUD 110.07M
销售成本
AUD 43.74M
流动资产
AUD 460.59M
流动负债
AUD 313.94M
债务
AUD 38.82M
EBIT
AUD -16.2M
EBITDA
AUD 20.9M
员工
450
EPS每股收益
AUD -0.15
股本和储备
AUD 454.19M
销售毛利
AUD 86.13M
债务利息支出
AUD 1.2M
贷款资金
AUD 2.66M
市值
AUD 195.67M
净收入
AUD -103.68M
营业费用
AUD 103.54M
营业利润
AUD -3.3M
普通股股本
AUD 81.25M
税前利润
AUD -14.7M
销售收入
AUD 212.07M
销售和管理费用
AUD 54.8M
股票
AUD 74.63M
贸易债权人
AUD 30.25M
应收帐款人
AUD 193.22M


税前利润 更改 日
Ansell USD 33.35M 74.15M 2025-06
Avita Medical AUD -11.64M 12.13M 2025-12
Cochlear AUD 121.1M 155.6M 2025-06
CSL USD 2.61B 1.21B 2025-12
Healius AUD -19.2M 3M 2025-06
Integral Diagnostics AUD 14.49M 47.37M 2024-06
Medical Developments International AUD -149K 466K 2025-06
Nanosonics AUD 11.39M 487K 2025-06
Polynovo AUD 1.96M 146K 2025-12
Ramsay Health Care AUD 103.75M 54.35M 2025-06
ResMed USD 496.15M 13.77M 2025-12
Sigma Healthcare AUD 8.15M 7.4M 2024-07
Sonic Healthcare AUD 402.01M 53.16M 2025-06
Telix Pharmaceuticals AUD 76.73M 66.04M 2025-06